On the interaction of alpha2-plasmin inhibitor and proteases. Evidence for the formation of a covalent crosslinkage and non-covalent weak bondings between the inhibitor and proteases
- PMID: 141946
- DOI: 10.1016/0005-2744(77)90255-8
On the interaction of alpha2-plasmin inhibitor and proteases. Evidence for the formation of a covalent crosslinkage and non-covalent weak bondings between the inhibitor and proteases
Abstract
alpha2-plasmin inhibitor is a proteinase inhibitor in plasma which efficiently inhibits the lysis of fibrin clots induced by plasminogen activator. The nature of the binding of the inhibitor to trypsin or plasmin was studied by the chemical treatment of the enzyme-inhibitor complex with 7.5 M hydrazine at pH 10.0. With the hydrazine treatment, the complexes were degraded to proteins corresponding to the respective enzyme and inhibitor moieties. These results indicate that the covalent bond between the inhibitor and the enzymes is a carboxylic ester. The binding reaction of the inhibitor to active site-modified trypsin was also studied. The inhibitor formed complexes with anhydrotrypsin and carboxyamidomethylated trypsin. The complexes were dissociated in the presence of 1% sodium dodecyl sulfate, to the individual components: the respective enzyme and inhibitor moieties. The inhibitor, however, did not form a complex with diisopropylphosphorylated trypsin regardless of the presence or absence of the denaturing reagent. These results suggest the contribution of non-covalent interactions to the complex formation between the inhibitor and native enzymes.
Similar articles
-
Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.J Biol Chem. 1976 Oct 10;251(19):5956-65. J Biol Chem. 1976. PMID: 134998
-
Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.J Clin Invest. 1975 Mar;55(3):593-604. doi: 10.1172/JCI107967. J Clin Invest. 1975. PMID: 123251 Free PMC article.
-
Inhibition of proteases by alpha 2-macroglobulin. The role of lysyl amino groups of trypsin in covalent complex formation.J Biol Chem. 1981 Oct 25;256(20):10409-14. J Biol Chem. 1981. PMID: 6169720
-
Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin-heparin complex.Blood Coagul Fibrinolysis. 2017 Sep;28(6):431-437. doi: 10.1097/MBC.0000000000000611. Blood Coagul Fibrinolysis. 2017. PMID: 27898513
-
Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma.Biochem J. 1978 Nov 1;175(2):635-41. doi: 10.1042/bj1750635. Biochem J. 1978. PMID: 154322 Free PMC article.
Cited by
-
The human plasma fibrinolytic system: regulation and control.Mol Cell Biochem. 1978 Aug 16;20(3):149-57. doi: 10.1007/BF00243761. Mol Cell Biochem. 1978. PMID: 151804 Review.
-
Inhibitory spectrum of alpha 2-plasmin inhibitor.Proc Natl Acad Sci U S A. 1979 Apr;76(4):2013-7. doi: 10.1073/pnas.76.4.2013. Proc Natl Acad Sci U S A. 1979. PMID: 156364 Free PMC article.
-
Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients.J Clin Invest. 1986 Aug;78(2):567-75. doi: 10.1172/JCI112610. J Clin Invest. 1986. PMID: 3734104 Free PMC article.
-
Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease.Front Cardiovasc Med. 2020 Dec 23;7:608899. doi: 10.3389/fcvm.2020.608899. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33426005 Free PMC article.
-
Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.J Thromb Haemost. 2008 Sep;6(9):1565-70. doi: 10.1111/j.1538-7836.2008.03056.x. Epub 2008 Jun 16. J Thromb Haemost. 2008. PMID: 18564219 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources